Superworth

Ultragenyx Pharmaceutical EPS RARE

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$5.84
Latest quarter, Q2 FY26
−$0.90
Fiscal year 2025
−$5.84

Ultragenyx Pharmaceutical's earnings per share was −$5.84 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.90.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$5.84n/a
FY2024−$6.34n/a
FY2023−$8.33n/a
FY2022−$10.11n/a
FY2021−$6.71n/a
FY2020−$3.14n/a
FY2019−$7.12n/a
FY2018−$3.91n/a
FY2017−$7.11n/a
FY2016−$6.20n/a
FY2015−$3.91n/a
FY2014−$2.32n/a
FY2013−$14.62n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.90n/a−$5.84
Q1 FY26−$1.84n/a−$6.11
Q4 FY25−$1.29n/a−$5.84
Q3 FY25−$1.81n/a−$5.94
Q2 FY25−$1.17n/a−$5.53
Q1 FY25−$1.57n/a−$5.88
Q4 FY24−$1.39n/a−$6.34
Q3 FY24−$1.40n/a−$6.47
Q2 FY24−$1.52n/a−$7.30
Q1 FY24−$2.03n/a−$8.03
Q4 FY23−$1.52n/a−$8.33
Q3 FY23−$2.23n/a−$8.97

Against its peers

Companies in Drug Manufacturers - General nearest Ultragenyx Pharmaceutical's size, closest first, today.

CompanyEPS, 12 monthsGrowth
RAREUltragenyx Pharmaceutical−$5.84
PAHCPhibro Animal Health$2.44+107% a year
ANABAnaptysbio$4.57
PCRXPacira BioSciences$0.35
ANIPANI Pharmaceuticals$4.70
OMEROmeros$1.52
HRMYHarmony Biosciences$3.09−0% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
PBHPrestige Consumer Healthcare$3.57−16% a year
NRIXNurix Therapeutics$2.31
ABUSArbutus Biopharma$0.78
Peer median$2.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Ultragenyx Pharmaceutical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.